Compound ID | 247
Class: Antimicrobial peptide
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Streptococcus pneumoniae, and enterococci |
| Propensity to select resistant mutants: | Yes, at 4x MIC |
| Description: | Natural product from Amycolatopsis fastidiosa (previously Nocardia sp.); a thiazolyl peptide; shows efficacy when administered via subcutaneous route in mice infected with Staphylococcus aureus |
| Institute where first reported: | Merck Research Laboratories, USA |
| Year first mentioned: | 2007 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/16156566 |
| Guide to Pharmacology: | Thiazomycin A |
| Citations: |
|